| Dr Scott Edward Silverman, MD | |
|
217 Manatee Ave E, Bradenton, FL 34208-1931 | |
| (941) 748-1818 | |
| (941) 746-1055 |
| Full Name | Dr Scott Edward Silverman |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 34 Years |
| Location | 217 Manatee Ave E, Bradenton, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912905910 | NPI | - | NPPES |
| 378684600 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | ME0068584 (Florida) | Secondary |
| 207WX0110X | Ophthalmology - Pediatric Ophthalmology And Strabismus Specialist | ME0068584 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Manatee Sarasota Eye Clinic Pa | 2466414925 | 11 |
News Archive
Nabi Biopharmaceuticals announced the receipt of a patent for treating and preventing nicotine addiction with NicVAX® and related nicotine conjugate vaccines. The United States Patent and Trademark office issued U.S. Patent No. 7,776,620 entitled "Hapten-carrier conjugates for treating and preventing nicotine addiction" for the exclusive use of methods for treating and preventing nicotine addiction with NicVAX and related nicotine vaccines. This patent runs through December 2018.
LightLab Imaging, Inc., pioneer and leader in the development of Optical Coherence Tomography (OCT) for coronary artery applications, today reported that Trial Judge Margaret Hinkle has set March 22 for the commencement of the next phase of an ongoing trial to address damages LightLab Imaging is claiming against Volcano Corporation and its wholly owned subsidiary, Axsun Technologies, Inc.
Merck & Co., Inc., which operates outside the U.S. and Canada as MSD, today announced the European Commission (EC) approval of ELONVA® (corifollitropin alfa injection). ELONVA is indicated for controlled ovarian stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (ART) program.
When children need kidney dialysis because of disease or congenital defects, doctors are forced to adapt adult-size dialysis equipment. No FDA-approved kidney replacement devices exist that are specifically designed for children.
Researchers studying strains of a lethal canine virus and a related human virus have determined why the canine virus was able to spread so quickly from cats to dogs, and then from sick dogs to healthy dogs.
› Verified 9 days ago
| Entity Name | Manatee Sarasota Eye Clinic Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093752149 PECOS PAC ID: 2466414925 Enrollment ID: O20041028000173 |
News Archive
Nabi Biopharmaceuticals announced the receipt of a patent for treating and preventing nicotine addiction with NicVAX® and related nicotine conjugate vaccines. The United States Patent and Trademark office issued U.S. Patent No. 7,776,620 entitled "Hapten-carrier conjugates for treating and preventing nicotine addiction" for the exclusive use of methods for treating and preventing nicotine addiction with NicVAX and related nicotine vaccines. This patent runs through December 2018.
LightLab Imaging, Inc., pioneer and leader in the development of Optical Coherence Tomography (OCT) for coronary artery applications, today reported that Trial Judge Margaret Hinkle has set March 22 for the commencement of the next phase of an ongoing trial to address damages LightLab Imaging is claiming against Volcano Corporation and its wholly owned subsidiary, Axsun Technologies, Inc.
Merck & Co., Inc., which operates outside the U.S. and Canada as MSD, today announced the European Commission (EC) approval of ELONVA® (corifollitropin alfa injection). ELONVA is indicated for controlled ovarian stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (ART) program.
When children need kidney dialysis because of disease or congenital defects, doctors are forced to adapt adult-size dialysis equipment. No FDA-approved kidney replacement devices exist that are specifically designed for children.
Researchers studying strains of a lethal canine virus and a related human virus have determined why the canine virus was able to spread so quickly from cats to dogs, and then from sick dogs to healthy dogs.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Scott Edward Silverman, MD 217 Manatee Ave E, Bradenton, FL 34208-1931 Ph: (941) 748-1818 | Dr Scott Edward Silverman, MD 217 Manatee Ave E, Bradenton, FL 34208-1931 Ph: (941) 748-1818 |
News Archive
Nabi Biopharmaceuticals announced the receipt of a patent for treating and preventing nicotine addiction with NicVAX® and related nicotine conjugate vaccines. The United States Patent and Trademark office issued U.S. Patent No. 7,776,620 entitled "Hapten-carrier conjugates for treating and preventing nicotine addiction" for the exclusive use of methods for treating and preventing nicotine addiction with NicVAX and related nicotine vaccines. This patent runs through December 2018.
LightLab Imaging, Inc., pioneer and leader in the development of Optical Coherence Tomography (OCT) for coronary artery applications, today reported that Trial Judge Margaret Hinkle has set March 22 for the commencement of the next phase of an ongoing trial to address damages LightLab Imaging is claiming against Volcano Corporation and its wholly owned subsidiary, Axsun Technologies, Inc.
Merck & Co., Inc., which operates outside the U.S. and Canada as MSD, today announced the European Commission (EC) approval of ELONVA® (corifollitropin alfa injection). ELONVA is indicated for controlled ovarian stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (ART) program.
When children need kidney dialysis because of disease or congenital defects, doctors are forced to adapt adult-size dialysis equipment. No FDA-approved kidney replacement devices exist that are specifically designed for children.
Researchers studying strains of a lethal canine virus and a related human virus have determined why the canine virus was able to spread so quickly from cats to dogs, and then from sick dogs to healthy dogs.
› Verified 9 days ago
Dr. Dana James Weinkle, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5601 21st Ave W, Suite A, Bradenton, FL 34209 Phone: 941-794-2020 Fax: 941-792-3464 | |
Dr. Liaquat Allarakhia, M.D., Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4812 26th St W, Bradenton, FL 34207 Phone: 941-727-3937 Fax: 941-727-7001 | |
Jonathan Adam Adler, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1509 53rd Ave W, Bradenton, FL 34207 Phone: 941-753-0220 Fax: 941-753-0279 | |
Richard E Hector, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6002 Pointe West Blvd, Bradenton, FL 34209 Phone: 941-792-2020 Fax: 941-782-1089 | |
Dr. Joshua Mali, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6002 Pointe West Blvd, Bradenton, FL 34209 Phone: 941-792-2020 | |
Jeffrey M Davis, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 217 Manatee Ave E, Bradenton, FL 34208 Phone: 941-748-1818 | |
Dr. Philip Lodge Ames, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 217 Manatee Ave E, Bradenton, FL 34208 Phone: 941-748-1818 Fax: 941-746-1055 |